Sakar Healthcare Limited

NSE:SAKAR.NS

$376.8 INR

$7.65 (2.07%)

Volume
3.83K
Average Volume
35.93K
Market Capitalization
$8.2B
P/E Ratio
65.71
Dividend Yield
0.00%
Price Target
$
Year High
$479.00
Year Low
$191.30
Payout Ratio
$0.00
Current Ratio
$0.00

Industry, Sector & symbol

Stock Exchange National Stock Exchange of India
CEO Mr. Sanjay Surendra Shah
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
Current Symbol SAKAR.NS
CUSIP Y7455Q100
CIK None
Web https://www.sakarhealthcare.com
Phone 91 79 2658 4655
Currency INR
Employees 297
Country IN

Liquidity

Debt-to-Equity Ratio 0.00
Payout Ratio 0.00
Current Ratio 0.00
Quick Ratio 0.00
Cash Ratio 0.00

Sales & Book Value

Annual Sales $1.33B
Price / Sales 5.43
Cash Flow 15.39
Price / Cash Flow 24.48
Price / Book 0.00

Price Target and Rating

Average Stock Price Forecast $
High Stock Price Forecast $
Low Stock Price Forecast $
Forecast Upside/Downside %
Consensus Rating Buy
Rating Score(0-5) 4
Research Coverage 0 Analysts

Profitability

EPS (Most Recent Fiscal Year) $6.86
Trailing P/E Ratio 65.71
PEG Ratio 3.50
P/E Growth 3.50
Net Income $127.59M
Net Margin 8.26%
Pretax Margin 9.93%
Return on Equity 8.55%
Return on Assets 0.00%

Financials Score

AltmanZ Score
Piotroski Score 4.00
Working Capital -
Total Assets -
Ebit 224.25M
Market Cap 8.18B
Total Liabilities -

Poll Results

About Sakar Healthcare Limited (NSE:SAKAR.NS) Stock

Sakar Healthcare Limited research, develops, manufactures, and markets pharmaceutical products in India. The company provides liquid orals, cephalosporin tablets, capsules, dry powder syrups, dry powder injections, liquid injectable SVP in ampoules, vials and lyophilized injections, and oral solid dosages. Its product portfolio consists of formulations in approximately 22 therapeutic areas, such as antacid, antimalerial, anticoagulant, laxative, anthelmintic, bronchodilator, anaesthetic, antidepressant, sedative, adrenergic, anti-infective, diuretics, oxytocic, analgesic, antiemetic, antipsychotic, antifungal, PPI, anticonvulsant, anti-inflammatory, antihistamine, and multi vitamins. The company also exports its products to approximately 38 countries, including Southeast Asia, Asia, Africa ... -Anglo and Francophone, MENA countries, and the United States. Sakar Healthcare Limited was incorporated in 2004 and is based in Ahmedabad, India.

Frequently Asked Questions

What is the current Sakar Healthcare Limited (SAKAR.NS) stock price?

Sakar Healthcare Limited(NSE:SAKAR.NS) stock price is $376.8 in the last trading session. During the trading session, SAKAR.NS stock reached the peak price of $479.0 while $191.3 was the lowest point it dropped to. The percentage change in SAKAR.NS stock occurred in the recent session was 2.07% while the dollar amount for the price change in SAKAR.NS stock was $7.65.

SAKAR.NS's industry and sector of operation?

The NSE listed SAKAR.NS is part of Drug Manufacturers—Specialty & Generic industry that operates in the broader Healthcare sector.

Who are the executives of SAKAR.NS?

Mr. Bharat S. Soni | Company Secretary & Compliance Officer
Mr. Sanjay Surendra Shah | Chairman & MD
Mr. Aarsh Sanjay Shah | Joint MD & Executive Director
Ms. Ritaben Sanjay Shah | Whole-Time Director
Mr. Dharmesh R. Thaker | Chief Financial Officer

How many employees does SAKAR.NS have?

Number of SAKAR.NS employees currently stands at 297. SAKAR.NS operates from 406, Silver Oaks Comm. Complex, Ahmedabad, None 380007, IN.

Link for SAKAR.NS official website?

Official Website of SAKAR.NS is: https://www.sakarhealthcare.com

How do I contact SAKAR.NS?

SAKAR.NS could be contacted at phone #91 79 2658 4655 and can also be accessed through its website. SAKAR.NS operates from 406, Silver Oaks Comm. Complex, Ahmedabad, None 380007, IN.

How many shares of SAKAR.NS are traded daily?

The average number of SAKAR.NS shares traded daily for last 3 months was 35.93K.

What is the market cap of SAKAR.NS currently?

The market value of SAKAR.NS currently stands at $8.2B with its latest stock price at $376.8